RyboDyn
Pre-clinicalRybodyn unlocks the dark proteome to develop first-in-class immunotherapies with AI and high-resolution RNA sequencing via its RyboCypher™ platform.
Founded
2018
Focus
Genetics & Genomics
About
Rybodyn unlocks the dark proteome to develop first-in-class immunotherapies with AI and high-resolution RNA sequencing via its RyboCypher™ platform.
Company Info
TypePrivate
Founded2018
LocationSan Diego, United States
StagePre-clinical
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile